Furthermore, the analysis of the TCGA data depicted inverse expression levels of microRNA-DUSP2 pairs between tumours and controls for members of the miR-17-92 and the miR-29 cluster e.g. in kidney or prostate cancer (Fig. 2). The gene discussed is DUSP2; the disease is prostate cancer.